Phase 1 Oncology Clinical Trial Designs: Adaptive Strategies That Accelerate Milestones and De-Risk Regulatory Approval
Precision for Medicine2025-12-1936 页
Phase 1 Oncology Clinical Trial Designs: Adaptive Strategies That Accelerate Milestones and De-Risk Regulatory Approval
Precision for Medicine2025-12-2136 页
Europe’s Beating Cancer Plan in Action: National Implementation for the Future
EFPIA Oncology Platform and Cancer Patients Europe2025-12-2541 页
2025 Biomedtracker Datamonitor Healthcare Post-ASH Report
Biomedtracker, Datamonitor Healthcare (Citeline, a Norstella company)2026-01-13111 页
Advancing Precision Oncology: Trends in Oncology Biomarker Testing in the U.S.
IQVIA Institute for Human Data Science2026-03-2030 页
The Evolving Role of Real-World Evidence in Oncology HTA Decision-Making: Opportunities and Challenges
IQVIA2026-03-2628 页
Advancing Equitable and Timely Access to Personalized Oncology Therapies: Middle East and Africa
IQVIA Institute for Human Data Science2026-03-2612 页
2026 Biomedtracker Datamonitor Healthcare Pre-ASCO Report
Evaluate2026-06-02135 页
破茧2026 · 基因编辑与基因治疗行业研究白皮书
医麦客2026-06-2132 页
Annual Completed Clinical Trials Report
Citeline (Pharma Intelligence UK Limited)2026-07-1538 页